-
There's A Reason Mallinckrodt Continues To Disclose A Protracted, Multi-Agency Probe Of Recently-Acquired Questcor Pharmaceuticals
Tuesday, June 2, 2015 - 10:48am | 828Read More...Protracted SEC Investigation of Questcor Could Haunt Mallinckrodt Investors Facts of Interest or Concern: In Aug-2014, Mallinckrodt PLC (NYSE: MNK) completed its acquisition of Questcor Pharmaceuticals In a letter dated 23-Apr-2015, the SEC confirmed Questcor's involvement in on-going...
